Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 5,035 shares at $24.35 ($116K) on 2026-09-04, disclosed to the SEC on 2026-09-08.
Scheduled sale ($116k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.35 | 3,745 | $91K | 78.9% |
| 2 | $18.88 | 1,290 | $24K | 21.1% |
| Total | $22.95 avg | 5,035 | $116K | 100% |
| Filing → |
| DYN | SELL | 2026-05-14 | $29K | — | Filing → |
| DYN | SELL | 2026-03-06 | $13K | — | Filing → |
| DYN | SELL | 2025-12-05 | $18K | — | Filing → |